CHMP4 proteins, integral components of the endosomal sorting complex required for transport (ESCRT) machinery, play essential roles in cellular division, viral release, and the endosomal-lysosomal degradation pathway. This family of proteins, which includes several isoforms such as CHMP4A, CHMP4B, and CHMP4C, is critical for mediating the vesicle budding process off the membrane of various cellular compartments. In the dynamic cellular environment, the expression of CHMP4 is tightly regulated and responds to various intracellular signals and stressors, ensuring the smooth operation of the cell's endosomal trafficking system and maintenance of its structural integrity. The precise mechanisms through which CHMP4 facilitates these processes are complex, involving a series of interactions with other protein components to form the ESCRT-III complex, which is pivotal for the abscission phase in cytokinesis and for the sorting of ubiquitinated proteins targeted for degradation.
The expression of CHMP4 can be influenced by a range of specific chemical compounds, which are known to interact with cellular signaling pathways or stress responses that could potentially serve as activators of CHMP4. Such compounds include tunicamycin and thapsigargin, which induce ER stress and may lead to an enhanced expression of CHMP4 as part of the cellular effort to manage protein folding and trafficking anomalies. Other agents, like Brefeldin A and MG132, disrupt the Golgi apparatus and proteasomal function, respectively, which could trigger compensatory mechanisms involving the upregulation of CHMP4 to maintain cellular homeostasis. Additionally, molecules like chloroquine and epothilone B, which alter endosomal acidification and microtubule dynamics, respectively, may also stimulate the expression of CHMP4, reflecting the cell's need to adapt to changes in intracellular transport and vesicle formation. The response to these compounds underscores the cell's reliance on the adaptability of the ESCRT machinery, of which CHMP4 is a critical element, to ensure efficient sorting and recycling of cellular components. It's important to note that while these chemical compounds can induce CHMP4 expression, their effects are part of a complex network of cellular responses.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin activates the unfolded protein response (UPR) due to ER stress, which may stimulate the transcription of CHMP4 as the cell attempts to restore normal function in vesicular trafficking and protein sorting. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels and provokes ER stress, potentially stimulating an upregulation of CHMP4 as a cellular adaptation to maintain homeostasis in vesicular transport mechanisms. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi complex, which could trigger an upsurge in CHMP4 expression to balance the altered endomembrane system dynamics. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasomal degradation, leading to a buildup of ubiquitinated proteins and possibly stimulating an increase in CHMP4 expression to enhance the cell's capacity for protein clearance and trafficking. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine impairs endosomal acidification, which could prompt a cellular response to increase CHMP4 expression to adjust to the disruptions in endosomal-lysosomal processing pathways. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Epothilone B stabilizes microtubules, possibly necessitating an upregulation of CHMP4 to preserve cellular logistics, including the sorting and delivery of membrane-bound proteins and vesicles. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U 18666A hampers intracellular cholesterol trafficking, potentially elevating CHMP4 expression as part of a compensatory response to mitigate the effects on lipid sorting and vesicular transport. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin suppresses mTOR activity, which could stimulate CHMP4 expression as part of the autophagic machinery, ramping up the degradation and recycling of cellular components. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG inhibits Hsp90, a chaperone involved in protein folding, possibly leading to an induction of CHMP4 expression to deal with misfolded proteins and enhance the cellular quality control systems. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through its nuclear receptors, can induce gene transcription including those involved in cellular differentiation and vesicle formation, which may include an upregulation of CHMP4. | ||||||